Form 4: Protagonist Therapeutics CEO Reports Share Transactions

Protagonist Therapeutics President and CEO Dinesh V. Patel reported gifting 50,000 common shares and exercising and selling 54,700 shares of common stock.

Summary

• Dinesh V. Patel, President and CEO of Protagonist Therapeutics, Inc. (PTGX), reported multiple transactions involving common stock.
• On March 23, 2026, Patel made a bona fide gift of 50,000 shares of common stock to relatives at a price of $0.00 per share.
• On March 24, 2026, Patel exercised 59 stock options at an exercise price of $8.58 per share and simultaneously sold 59 shares of common stock at $101 per share.
• On March 25, 2026, Patel exercised 54,641 stock options at an exercise price of $8.58 per share and simultaneously sold 54,641 shares of common stock at $101 per share.
• All exercised stock options were fully vested.
• Following these transactions, Patel beneficially owns 524,938 shares of common stock.
• The reported beneficial ownership includes 433 shares acquired under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While there is a net reduction in direct beneficial ownership due to a gift and sales, the sales are likely related to option exercises for liquidity or tax purposes, and the high sale price is favorable for the insider.

Positives

• The exercise of stock options at $8.58 and subsequent sale at $101 indicates a significant profit for the reporting person on those specific shares.

Negatives

• The net effect of the transactions is a reduction in direct beneficial ownership by 50,000 shares due to the gift, plus the sale of 54,700 shares that were immediately exercised from options.
• Insider selling, even if pre-planned or for personal reasons, can sometimes be perceived negatively by the market.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported in a Form 4, are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. While a gift is a personal transaction, and option exercises followed by sales are often for liquidity or tax planning, the overall activity contributes to the market's perception of insider sentiment.

Related Party Transactions

• A bona fide gift of 50,000 common shares was made by the reporting person to relatives on March 23, 2026.

Stakeholder Impact

• Shareholders may interpret the net reduction in direct beneficial ownership by the CEO as a signal, though the transactions appear to be part of routine personal financial management (gift, option exercise and sale).

Key Dates

Recommendation

The Form 4 filing details routine insider transactions including a gift and the exercise and sale of stock options. While there is a net reduction in the CEO's direct beneficial ownership, these transactions are often pre-planned or for personal financial management and do not inherently signal a change in the company's fundamental outlook. Without additional financial or strategic information, a 'hold' recommendation is appropriate as this filing alone does not provide sufficient grounds for a strong buy or sell decision.

Keywords

Protagonist Therapeutics, PTGX, Dinesh Patel, Insider Trading, Form 4, Stock Options, Share Sale, Gift of Securities, CEO Transactions